Enter your email address:

Delivered by FeedBurner

China File’s Patent For Gilead’s New Coronavirus Drug

Chinese researchers at the Wuhan Institute of Virology situated at the
epicenter of coronavirus outbreak, Wuhan, have applied for a patent in
China on an experimental Gilead Sciences Inc. antiviral drug,
remdesivir that they believe might fight the novel coronavirus
outbreak. According to a statement on the institute's website made on
Feb. 4, the patent […]

The post China File's Patent For Gilead's New Coronavirus Drug
appeared first on BioTecNika .


Biotech News


Post a Comment